Cargando…

Development and Palatability Assessment of Norvir(®) (Ritonavir) 100 mg Powder for Pediatric Population

Norvir(®) (ritonavir) is a Biopharmaceutical Classification System Class IV compound with poor solubility in water (~5 µg/mL) and limited oral bioavailability. Early stage development efforts were focused on an oral solution (OS) which provided reasonable bioavailability but exhibited taste-masking...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morris, John B., Tisi, David A., Tan, David Cheng Thiam, Worthington, Jeffrey H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479559/ https://www.ncbi.nlm.nih.gov/pubmed/30959935 http://dx.doi.org/10.3390/ijms20071718

Ejemplares similares

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial
por: Cooper, David A., et al.
Publicado: (2016)

Pharmacokinetic Interaction Between Isavuconazole and a Fixed‐Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects
por: Yamazaki, Takao, et al.
Publicado: (2016)

Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients
por: Nadler, Jeffrey P, et al.
Publicado: (2003)

Concentrated and Palatable Powders
por: Southworth, J. W.
Publicado: (1874)

The Palatability of Lopinavir and Ritonavir Delivered by an Innovative Freeze-Dried Fast-Dissolving Tablet Formulation
por: Pittman, David W., et al.
Publicado: (2018)

Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet
por: Badawi, Mohamed, et al.
Publicado: (2022)

Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
por: Schneider, L, et al.
Publicado: (2010)

Long-term efficacy and safety of low-dose ritonavir-boosted atazanavir (ATV/r) 200/100 mg in HIV-infected Thai patients
por: Avihingsanon, A, et al.
Publicado: (2010)

Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers
por: Jackson, AGA, et al.
Publicado: (2010)

Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL
por: Casado, JL, et al.
Publicado: (2010)

Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT
por: Smith, Kimberly Y, et al.
Publicado: (2008)

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily
por: Zorrilla, CD, et al.
Publicado: (2014)

Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study
por: Bianco, Claudia, et al.
Publicado: (2014)

Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study
por: Ghosn, J, et al.
Publicado: (2010)

Pediatric Palatal Fibroma
por: Mishra, Rahul, et al.
Publicado: (2017)

Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects
por: Swerdlow, Russell H., et al.
Publicado: (2016)

Pediatric Pleomorphic Adenoma of the Palate
por: Lindeboom, Jerome A., et al.
Publicado: (2021)

Ignition and Combustion Characteristic of B·Mg Alloy Powders
por: Ma, Yusong, et al.
Publicado: (2022)

Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
por: Alvarez, Jean Claude, et al.
Publicado: (2020)

Benefits of nirmatrelvir–ritonavir remain unproven for some populations
por: McDonald, Emily G., et al.
Publicado: (2022)

Population-Level Strategies for Nirmatrelvir/Ritonavir Prescribing—A Cost-effectiveness Analysis
por: Savinkina, Alexandra, et al.
Publicado: (2022)

Kinetics and Combustion Behavior of Atomized Zn–Mg Alloy Powder
por: Zhang, Ming-xing, et al.
Publicado: (2023)

Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
por: Dickinson, Laura, et al.
Publicado: (2009)

Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19
por: Mohsenian Naghani, Shaghayegh, et al.
Publicado: (2023)

Formulation development and rheological studies of palatable cefetamet pivoxil hydrochloride dry powder suspension
por: Sateesha, SB., et al.
Publicado: (2011)

Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel
por: Itkonen, Matti K., et al.
Publicado: (2018)

The acute effects of thermogenic fitness drink formulas containing 140 mg and 100 mg of caffeine on energy expenditure and fat metabolism at rest and during exercise
por: Clark, Nicolas W., et al.
Publicado: (2020)

Impact of the Morphology of Micro- and Nanosized Powder Mixtures on the Microstructure of Mg-Mg(2)Si-CNT Composite Sinters
por: Olszówka-Myalska, Anita, et al.
Publicado: (2019)

Low dose Mifepristone (100 mg) for medical termination of pregnancy
por: Seth, Shikha, et al.
Publicado: (2011)

Investigation of LiF, Mg and Ti (TLD-100) Reproducibility
por: Sadeghi, M., et al.
Publicado: (2015)

Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers
por: Radicioni, Milko, et al.
Publicado: (2017)

Practical Approach to Eliminate Solidification Cracks by Supplementing AlMg4.5Mn0.7 with AlSi10Mg Powder in Laser Powder Bed Fusion
por: Böhm, Constantin, et al.
Publicado: (2022)

Pediatric Myofibroma of the Palate with Ulceration and Bone Destruction
por: Capo, Joseph A., et al.
Publicado: (2016)

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
por: Antoniou, Tony, et al.
Publicado: (2017)

Palatal rugoscopy as an adjunct for sex determination in forensic odontology (Sri Ganganagar population): A cross-sectional study of 100 subjects
por: Gupta, Vineet, et al.
Publicado: (2021)

Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis
por: Zeng, Chao, et al.
Publicado: (2015)

Abrocitinib 100 mg versus 200 mg for atopic dermatitis: a meta-analysis of randomized controlled trials
por: Wang, Junqiao, et al.
Publicado: (2022)

A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine
por: Dahlöf, Carl, et al.
Publicado: (2004)

Inhibition of osteoblast differentiation by ritonavir
por: Wakabayashi, Yoshitaka, et al.
Publicado: (2018)

Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eo4fbd836gu4d32ki23vfuh3kc